×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
MGRX – mangoceuticals, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
MGRX
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
10/31
08:00 am
mgrx
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
Medium
Report
Mangoceuticals, Inc. Regains Full Compliance with Nasdaq Minimum Bid Price Requirement
10/22
08:00 am
mgrx
MangoRx Announces Formation of Strategy and Alternatives Committee
Low
Report
MangoRx Announces Formation of Strategy and Alternatives Committee
10/21
05:10 pm
mgrx
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
Medium
Report
MangoRx Responds to and Refutes Recent Claims Made by Eli Lilly
10/11
05:15 pm
mgrx
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
High
Report
MANGOCEUTICALS, INC. ANNOUNCES 1-FOR 15 REVERSE STOCK SPLIT AS PART OF NASDAQ COMPLIANCE PLAN
10/3
08:30 am
mgrx
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
High
Report
MangoRx Introduces Oral Tirzepatide GLP-1 Receptor Agonist for Advanced Weight Loss Solutions
10/1
07:30 am
mgrx
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
Medium
Report
MangoRx Addresses $49.3 Billion Global GLP-1 Market With Launch of Oral Semaglutide for Advanced Weight Loss Treatment
8/15
09:25 am
mgrx
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
Medium
Report
MangoRx Reports 1,685% Increase in Shareholders’ Equity From December 31, 2023, to $13.8MM, and 56% Increase in Year-Over-Year Revenue for First Half of 2024
8/13
04:00 pm
mgrx
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent
High
Report
MangoRx Receives Certificate of Grant in India for its Respiratory Illness and Preventive Care Technology Patent
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Action
From
To
Firm
Impact
%Chg
Date
Time
Symbol
Headline
Impact
10/31
08:01 am
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 30
Medium
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 30
10/25
05:01 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 18
Low
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 18
10/22
08:00 am
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 18
Low
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 18
10/21
05:10 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 21
High
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 21
10/11
05:15 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 08
Medium
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 08
10/3
08:31 am
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 03
High
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 03
10/2
05:25 pm
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Aug 15
Medium
Report
Form 8-K MANGOCEUTICALS, INC. For: Aug 15
10/1
07:30 am
mgrx
Form 8-K MANGOCEUTICALS, INC. For: Oct 01
Low
Report
Form 8-K MANGOCEUTICALS, INC. For: Oct 01
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: